$6.54
0.162.51%
Last update: Nov 6, 4:00 PM
Bolt Biotherapeutics Inc
BOLTNASDAQ
The average analyst price target for Bolt Biotherapeutics is $28.80, 382.4% above the current price. Of 7 analysts, 3 rate it Buy and 4 Hold. Targets range from $7 to $75. The latest change came on May 29, 2026, when Rodman & Renshaw initiated coverage of Bolt Biotherapeutics with a Buy rating and a $22 price target.
Price Target Range — 8 Quarters
Analyst Consensus — 7 Analysts
Rating Trend — Last 9 Months
